Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vistagen Therapeutics (VTGN) Non Operating Income (2025)

Vistagen Therapeutics (VTGN) has disclosed Non Operating Income for 2 consecutive years, with $6000.0 as the latest value for Q3 2025.

  • Quarterly Non Operating Income changed N/A to $6000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $600.0 for FY2021, N/A changed from the prior year.
  • Non Operating Income hit $6000.0 in Q3 2025 for Vistagen Therapeutics, up from -$2000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $6000.0 in Q3 2025 to a low of -$2000.0 in Q2 2025.